tiprankstipranks
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
US Market

Adaptive Biotechnologies (ADPT) Income Statement

Compare
888 Followers

Adaptive Biotechnologies Income Statement

Last quarter (Q3 2024), Adaptive Biotechnologies's total revenue was $46.44M, an increase of 22.46% from the same quarter last year. In Q3, Adaptive Biotechnologies's net income was $-32.07M. See Adaptive Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 170.28M$ 185.31M$ 154.34M$ 98.38M$ 85.07M
Gross Profit
$ 94.72M$ 127.40M$ 105.04M$ 75.85M$ 62.80M
Operating Expenses
$ 321.76M$ 327.58M$ 314.01M$ 228.67M$ 141.19M
Depreciation and Amortization
$ 22.23M$ 28.15M$ 20.98M$ 11.74M$ 7.79M
EBITDA
$ -189.27M$ -167.98M$ -193.34M$ -144.34M$ -70.60M
Operating Income
$ -227.03M$ -200.19M$ -208.97M$ -152.82M$ -78.39M
Other Income/Expenses
$ 1.73M$ -182.00K$ 1.67M$ 6.59M$ 9.79M
Pretax Income
$ -225.30M$ -200.37M$ -207.30M$ -146.23M$ -68.61M
Net Income
$ -225.25M$ -142.46M$ -205.61M$ -139.64M$ -58.82M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.56$ -1.00$ -1.46$ -1.06$ -0.85
Diluted EPS
$ -1.56$ -1.00$ -1.46$ -1.06$ -0.85
Weighted Average Shares Outstanding
144.38M 142.52M 140.35M 131.22M 69.17M
Weighted Average Shares Outstanding (Diluted)
144.38M 142.52M 140.35M 131.22M 69.17M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis